GOSSAMER BIO, INC. (GOSS) Operating income 2017–2025
GOSSAMER BIO, INC. (GOSS) annual operating income history from SEC filings — each fiscal year as reported.
-$170.7MFY2025 · since FY2017: -$6.7M → -$170.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$170.7M | -184.9% |
| FY2024 | -$59.9M | +67.4% |
| FY2023 | -$183.8M | +15.9% |
| FY2022 | -$218.6M | -1.1% |
| FY2021 | -$216.1M | +7.6% |
| FY2020 | -$234.0M | -25.7% |
| FY2019 | -$186.1M | -24.9% |
| FY2018 | -$149.0M | -2139.5% |
| FY2017 | -$6.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GOSS financial trends
GOSS RevenueGOSS Net incomeGOSS Net marginGOSS Gross profitGOSS Gross marginGOSS Operating marginGOSS Operating cash flowGOSS Free cash flowGOSS Capital expendituresGOSS Return on equityGOSS Stock buybacksGOSS Dividends paidGOSS Total assetsGOSS Total liabilitiesGOSS Shareholders’ equityGOSS overview →